[Federal Register: November 26, 2003 (Volume 68, Number 228)]
[Notices]
[Page 66442-66447]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26no03-64]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Grant for Injury Control Research Center

    Announcement Type: New.
    Funding Opportunity Number: 04057.
    Catalog of Federal Domestic Assistance Number: 93.136.
    Key Dates:
    Letter of Intent Deadline: December 26, 2003.
    Application Deadline: February 23, 2004.

I. Funding Opportunity Description

    Authority: This program is authorized under sections 301(a) and
391(a)(1) of the Public Health Service Act, (42 U.S.C.
241(a)280b(a)(1)), as amended.
    Purpose: The Centers for Disease Control and Prevention (CDC)
announces the availability of fiscal year (FY) 2004 funds for a grant
for an Injury Control Research Center (ICRC). This program addresses
the ``Healthy People 2010'' focus area of Injury and Violence
Prevention. A copy of ``Healthy People 2010'' is available at the
following Internet address: http://www.health.gov/healthypeople.
    The purposes of this program are:
    1. To support an ICRC in a state predominately comprised of
economically depressed rural communities where a relatively large
portion of the work force is engaged in underground mining, family
farming, and other rural occupations.
    2. To support injury prevention and control research on priority
issues as delineated in: ``Healthy People 2010''; ``Reducing the Burden
of Injury: Advancing Prevention and Treatment''; and the research
priorities published in the CDC Injury Research Agenda, located at
http://www.cdc.gov/ncipc.
    3. To integrate, in the context of a national program, the
disciplines of epidemiology, medicine, biomechanics and other
engineering, biostatistics, public health, law and criminal justice,
and behavioral and social sciences in order to prevent and control
injuries more effectively.
    4. To define the injury problem; identify risk and protective
factors; develop and evaluate prevention and control interventions and
strategies; and ensure widespread adoption of effective interventions
and strategies.
    5. To provide technical assistance to injury prevention and control
programs within a geographic region.
    Measurable outcomes of the program will be in alignment with the
following performance goal for the National Center for Injury
Prevention and Control: Conduct a targeted program of research to
reduce injury-related death and disability.
    Research Objectives: Center funding is to be designated for two
types of activities. One type of activity is considered core and
includes administration, management, general support services (e.g.,
statistical, library, media relations, and advocacy for injury
prevention and control) as well as activities associated with research
development, technical assistance, and education (e.g., seed projects,
training activities, and collaborative and technical assistance
activities with other groups). Funds may be allocated for trainee
stipends, tuition remission, and trainee travel in accordance with the
current rates for the United States Public Health Service agencies.
Indirect costs for these trainee-related activities are limited to
eight percent. Defined research projects constitute the second type of
activity, and ICRCs are encouraged to work toward addressing the
breadth of the field. Core activities and defined research projects may
each constitute between 25 percent and 75 percent of the operating
budget, and should be balanced in such a way that the ICRC demonstrates
productivity in research as well as teaching and service. Applicants
with less demonstrated expertise in research are encouraged to devote a
larger percentage of funds to defined research projects in order to
establish their capability as research centers of excellence.
    At least 80 percent of the costs (total direct and indirect costs)
of the approved small and large research projects must be in alignment
with the ``CDC Injury Research Agenda,'' http://www.cdc.gov/ncipc.
    Eligible applicants may enter into contracts, including consortia
agreements, as necessary to meet the requirements of the program and
strengthen the overall application.
    Activities: Awardee activities for this program are as follows:
    1. Applicants must demonstrate expertise and experience in
conducting and publishing injury research in at least one of the three
phases of injury control (prevention, acute care, or rehabilitation)
and are encouraged to be comprehensive.
    2. Applicants must document ongoing injury control-related research
projects and activities currently supported by other sources of
funding.
    3. Applicants must provide a director (Principal Investigator) who
has specific authority and responsibility to carry out the project. The
director must report to

[[Page 66443]]

an appropriate institutional official, e.g., dean of a school, vice
president of a university, or commissioner of health. The director must
have no less than thirty percent effort devoted solely to this project
with an anticipated range of thirty percent to fifty percent.
    4. Applicants must provide evidence of working relationships,
including consultation and technical assistance, with outside agencies
and other entities in the region in which the ICRC is located which
will allow for implementation and evaluation of any proposed
intervention activities.
    5. Applicants must provide evidence of involvement of specialists
or experts in medicine, biomechanics and other engineering,
epidemiology, law and criminal justice, behavioral and social sciences,
biostatistics, and public health as needed to complete the plans of the
center. These are considered the disciplines and fields for ICRCs.
    6. Applicants must have established curricula and graduate training
programs in disciplines relevant to injury control (see item 5.above.).
    7. Applicants must disseminate injury control research findings,
translate them into interventions (i.e., programs or policies), and
evaluate their effectiveness.

II. Award Information

    Type of Award: Grant.
    Fiscal Year Funds: FY 2004.
    Approximate Total Funding: $905,500 (total of direct and indirect
costs).
    Approximate Number of Awards: One award.
    Approximate Average Award: $905,500.
    Floor of Award Range: None.
    Ceiling of Award Range: Applicants will be allowed to apply for
$1,055,500 ($150,000 above the expected award amount to allow for the
inclusion of the description of an additional large project as
described in Section IV. Application and Submission Information,
Application 4.b. (2), but the award will be no more than $905,500
(total of direct and indirect costs).
    Anticipated Award Date: September 1, 2004.
    Budget Period Length: Twelve months.
    Project Period Length: Three years.
    Throughout the project period, CDC's commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal Government.

III. Eligibility Information

    1. Eligible applicants: This announcement will provide funding for
applicants in regions that do not have funded Injury Control Research
Centers (ICRCs) and for applicants in regions that have funded Centers
that must re-compete for funding.
    Eligible applicants are limited to organizations in Department of
Health and Human Services (DHHS) Region II (New Jersey, New York,
Puerto Rico, and Virgin Islands), Region III (Delaware, District of
Columbia, Maryland, Pennsylvania, Virginia, and West Virginia), and
Region VI (Arkansas, Louisiana, New Mexico, Oklahoma, and Texas).

    Note: ICRC grant awards are made to the applicant institution/
organization, not the Principal Investigator.

    Applications may be submitted by public and private nonprofit and
for profit organizations and by governments and their agencies, such
as:

[sbull] Public nonprofit organizations
[sbull] Private nonprofit organizations
[sbull] For profit organizations
[sbull] Small, minority, women-owned businesses
[sbull] Universities
[sbull] Colleges
[sbull] Research institutions
[sbull] Hospitals
[sbull] Community-based organizations
[sbull] Faith-based organizations
[sbull] Federally recognized Indian tribal governments
[sbull] Indian tribes
[sbull] Indian tribal organizations
[sbull] State and local governments or their Bona Fide Agents (this
includes the District of Columbia)
[sbull] Political subdivisions of States (in consultation with States)

    A Bona Fide Agent is an agency/organization identified by the state
as eligible to submit an application under the state eligibility in
lieu of a state application. If you are applying as a bona fide agent
of a state or local government, you must provide a letter from the
state or local government as documentation of your status. Place this
documentation behind the first page of your application form.
    2. Cost Sharing or Matching: Matching funds are not required for
this program.
    3. Other Eligibility Requirements: If you request a funding amount
greater than the ceiling of the award range ($1,055,500), your
application will be considered non-responsive and will not be entered
into the review process. You will be notified that you did not meet the
submission requirements.

    Note: Title 2 of the United States Code section 1611 states that
an organization described in section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant, or loan.

IV. Application and Submission Information

    1. Address to Request Application Package: To apply for this
funding opportunity, use application form PHS 398 (OMB number 0925-0001
rev. 5/2004). Forms and instructions are available in an interactive
format on the CDC web site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm
.
    Forms and instructions are also available in an interactive format
on the National Institutes of Health (NIH) web site at the following
Internet address: http://grants.nih.gov/grants/funding/phs398/phs398.html
.
    If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: (770) 488-2700. Application forms can be mailed to
you.

2. Content and Form of Application Submission:

    Letter of Intent (LOI): CDC requests that you send a LOI if you
intend to apply for this program. Although the LOI is not required, not
binding, and does not enter into the review of your subsequent
application, your LOI will be used to gauge the level of interest in
this program, and to allow CDC to plan the application review. Your LOI
must be written in the following format:

[sbull] Maximum number of pages: Two
[sbull] Font size: 12-point unreduced
[sbull] Single Spaced
[sbull] Paper size: 8.5 by 11 inches
[sbull] Page margin size: one inch
[sbull] Printed only on one side of page
[sbull] Written in English, avoid jargon

Your LOI must contain the following information:

[sbull] Descriptive title of the proposed research
[sbull] Name, address, email address, and telephone number of the
Principal Investigator
[sbull] Names of other key personnel
[sbull] Participating institutions
[sbull] Number and title of this Program Announcement (PA)

    Application:  Follow the PHS 398 application instructions for
content and formatting of your application. For further assistance with
the PHS 398 application form, contact GrantsInfo, Telephone (301) 435-0714, E-mail: GrantsInfo@nih.gov.

[[Page 66444]]

    Your research plan should address activities to be conducted over
the entire project period.
    You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. Your DUNS number must be entered
in item 11 of the face page of the PHS 398 application form. The DUNS
number is a nine-digit identification number, which uniquely identifies
business entities. Obtaining a DUNS number is easy and there is no
charge. To obtain a DUNS number, access http://www.dunandbradstreet.com
or call 1-866-705-5711. For more information, see the CDC web site at:
http://www.cdc.gov/od/pgo/funding/pubcommt.htm.
    The Program Announcement title and number must appear in the
application. Use the information in Section I. Funding Opportunity
Description, Activities; Section V. Application Review Information; and
Section VI. Award Administration Information, Administration and
National Policy Requirements to develop the application content.
Applications should include the following information, detailing
activities to be conducted for the first budget year, while briefly
addressing activities to be conducted over the entire three-year
project period.
    1. Face page.
    2. Description (abstract) and personnel.
    3. Table of contents.
    4. Detailed budget for the initial budget period: The budget should
reflect the composite figures for the grant. In addition, separate
budgets (direct and indirect costs) and justifications should be
provided for the following categories of activities:
    a. Core activities, including management and administrative
functions, other non-research activities (e.g., education/training,
consultation, technical assistance, translation/dissemination, program
and policy development and evaluation, advocacy, and media activities,
etc.), and small seed projects of less than $25,000 (total of direct
and indirect costs) for one year or less.
    b. Research Studies:
    (1) Small studies of $25,000-150,000/year (total of direct and
indirect costs) for one to three years duration. These projects might
be expansions of seed projects, either further developing methods or
hypotheses in preparation for a larger investigation leading to the
submission of an RO1 level proposal, or might be stand-alone
investigations sufficient to yield results worthy of publication in a
peer-reviewed journal and/or a technical report for a legislative body,
governmental agency, or injury control program.
    (2) Larger scale studies with annual budgets exceeding $150,000/
year (total of direct and indirect costs) and lasting up to three
years. These projects typically will test hypotheses and employ more
sophisticated methodologies and/or larger sample sizes than small
studies.
    For seed projects, only modest budget descriptions are required
within the application. More detailed budget descriptions, commensurate
with costs, are required for both small studies and large research
projects.
    An applicant organization has the option of having specific salary
and fringe benefit amounts for individuals omitted from the copies of
the application that are made available to outside reviewing groups. To
exercise this option: On the original and two copies of the
application, the applicant must use asterisks to indicate those
individuals for whom salaries and fringe benefits are not shown; the
subtotals must still be shown. In addition, the applicant must submit
an additional copy of page four of Form PHS-398, completed in full,
with the asterisks replaced by the salaries and fringe benefits. This
budget page will be reserved for internal staff use only.
    5. Budget for entire proposed project period including budgets
pertaining to consortium/contractual arrangements.
    6. Biographical sketches of key personnel, consultants, and
collaborators, beginning with the Principal Investigator and core
faculty.
    7. Other support: This listing should include all other funds or
resources pending or currently available. For each grant or contract
include source of funds, amount of funding (indicate whether pending or
current), date of funding (initiation and termination), and
relationship to the proposed program.
    8. Resources and environment.
    9. Research plan:
    a. ICRCs are to develop a range of research and other non-research
activities that are designed to advance the field of injury control
through development of new scientific or surveillance methods, creation
of new knowledge, and translation of knowledge into training, program
and policy development and evaluation activities or other applications
that will ultimately reduce injuries or their effects. ICRC
applications should articulate how the activities of their program are
integrated with each other.
    b. A detailed research plan (design and methods), in accordance
with NCIPC's performance goal as stated in the purpose section of this
announcement, including hypothesis, expected outcome, value to the
field, and measurable and time-framed objectives consistent with the
activities for each project within the proposed grant.
    (1) Initial seed projects require a short write-up describing the
injury control context of the study, the objective, the design, the
setting and participants, the intervention being addressed, main
outcome measurements, expected results, time lines, cost (total of
direct and indirect costs), plans for translation/dissemination, and
clear definition of procedures used to select the projects. Clear
definitions of procedures used to select future out-year seed projects
are also required.
    (2) Small research projects require a ten to fifteen page summary
describing the accomplishment of all the steps, including a description
of the significance of the project, the development and testing of
methods and instruments, and the collection of preliminary data needed
to take an innovative approach and develop it to the level of a larger
investigation leading to the submission of an RO1 level proposal or a
stand-alone investigation sufficient to yield results worthy of
publication in a peer-reviewed journal and/or a technical report for a
legislative body, governmental agency, or injury control program.
    (3) Large research projects require an RO1 level summary as
described in the PHS 398 (Revised 5/01 and updated 6/28/02) guidelines.
The summary should be included as an appendix of the application.
    In the research plan section of the application include a
description for each small and large research project:
    a. Title of Project.
    b. Project Director/Lead Investigator.
    c. Institution(s).
    d. Categorization as Prevention, Acute Care, Rehabilitation, or
Biomechanics.
    e. Categorization as to which NCIPC research agenda priority area
the project addresses. Also, a brief description on how it addresses
that priority area. If a priority area is not addressed, provide an
explanation of why it is important.
    f. Categorization as Seed Project, Small Project, or Large Project.
    g. Categorization as New or Ongoing Project
    h. Cost/Year (total of direct and indirect costs).
    i. Research Training: Names, Degrees of Persons Trained or in
Training.
    j. Key Words.

[[Page 66445]]

    k. Brief Summary of Project including Intended Application of
Finding (Abstract).
    c. A description of the core faculty and their roles in
implementing and evaluating the proposed programs. The applicant should
clearly specify how disciplines will be integrated to achieve the
ICRC's objectives.
    d. Charts showing the proposed organizational structure of the ICRC
and its relationship to the broader institution of which it is a part
and, where applicable, to affiliate institutions or collaborating
organizations. These charts should clearly detail the lines of
authority as they relate to the center, both structurally and
operationally. ICRC directors should report to an appropriate
organizational level (e.g. dean of a school, vice president of a
university, or commissioner of health), demonstrating strong
institution-wide support of ICRC activities and ensuring oversight of
the process of interdisciplinary activity.
    e. Documentation of the public health agencies and other public and
private sector entities to be involved in the proposed program,
including letters that detail commitments of support and a clear
statement of the role, activities, and participating personnel of each
agency or entity.
    3. Submission Dates and Times:
    LOI Deadline Date: December 26, 2003.
    Application Deadline Date: February 23, 2004.
    Explanation of Deadlines: Applications must be received in the CDC
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline
date. If you send your application by the United States Postal Service
or commercial delivery service, you must ensure that the carrier will
be able to guarantee delivery of the application by the closing date
and time. If CDC receives your application after closing due to: (1)
Carrier error, when the carrier accepted the package with a guarantee
for delivery by the closing date and time, or (2) significant weather
delays or natural disasters, you will be given the opportunity to
submit documentation of the carrier's guarantee. If the documentation
verifies a carrier problem, CDC will consider the application as having
been received by the deadline.
    This announcement is the definitive guide on application submission
address and deadline. It supersedes information provided in the
application instructions. If your application does not meet the
deadline above, it will not be eligible for review, and will be
discarded. You will be notified that you did not meet the submission
requirements.
    CDC will not notify you upon receipt of your application. If you
have a question about the receipt of your application, first contact
your courier. If you still have a question, contact the PGO-TIM staff
at: 770-488-2700. Before calling, please wait two to three days after
the application deadline. This will allow time for applications to be
processed and logged.
    4. Intergovernmental Review: Executive Order 12372 does not apply
to this program.
    5. Funding restrictions: Restrictions, which must be taken into
account while writing your budget are as follows:
    Grant funds will not be made available to support the provision of
direct care. Studies may be supported which evaluate methods of acute
care and rehabilitation for potential reductions in injury effects and
costs. Studies may be supported which identify the effect on injury
outcomes and cost of systems for pre-hospital, hospital, and
rehabilitative care and independent living.
    If you are requesting indirect costs in your budget, you must
include a copy of your indirect cost rate agreement. If your indirect
cost rate is a provisional rate, the agreement must be less than 12
months of age.
    Awards will not allow reimbursement of pre-award costs.
    6. Other Submission Requirements:
    LOI Submission Address: Submit your LOI by express delivery
service, fax, or e-mail to (only one submission is required): Robin
Forbes, Center for Injury Prevention and Control, Centers for Disease
Control and Prevention (CDC), 4770 Buford Hwy., NE, Mailstop K-62,
Atlanta, GA 30341, Telephone: 770-488-4037, Fax: 770-488-1662, Email: CIPERT@cdc.gov.
    Application Submission Address: Submit the original and five copies
of your application by mail or express delivery service to: Technical
Information Management-PA 04057, Procurement and Grants
Office, Centers for Disease Control and Prevention (CDC), 2920
Brandywine Road, Atlanta, GA 30341.
    Applications may not be submitted electronically at this time.

V. Application Review Information

    1. Review: You are required to provide measures of effectiveness
that will demonstrate the accomplishment of the various identified
objectives of the grant. Measures of effectiveness must relate to the
performance goals stated in the ``Purpose'' section of this
announcement. Measures must be objective and quantitative, and must
measure the intended outcome. These measures of effectiveness must be
submitted with the application and will be an element of evaluation.
    2. Review and Selection Process: Applications will be reviewed by
CDC staff for completeness and responsiveness as outlined under the
previous heading Application and Submission Information. Incomplete
applications and applications that are not responsive will be returned
to the applicant without further consideration.
    Applications which are complete and responsive will be subjected to
a preliminary evaluation (streamline review) by the Initial Review
Group (IRG) to determine if the application is of sufficient technical
and scientific merit to warrant further review by the IRG. Applications
that are determined noncompetitive will not be considered, and NCIPC
will promptly notify the investigator/program director and the official
signing for the applicant organization. Applications determined to be
competitive will be evaluated by a dual review process.
    Awards will be made based on priority scores assigned to
applications by the IRG, programmatic priorities and needs determined
by a secondary review committee (the Advisory Committee for Injury
Prevention and Control), and the availability of funds.
1. Review by IRG
    An initial streamline peer-review of ICRC grant applications will
be conducted by the IRG. The IRG may recommend the application for a
site visit review. For those applications recommended for a site visit
review, a team of peer reviewers, including members of the IRG, will
conduct on-site visits at each applicant institution, generate summary
statements for the visits, and report the assessment to the IRG.
    Factors to be considered by the IRG include:
    a. The specific aims of the application, e.g., the long-term
objectives and intended accomplishments. Approval of small and large
research projects (including new research projects proposed during the
three-year funding cycle), in accordance with NCIPC's performance goal
as stated in section ``B. Purpose'', is subject to peer review.
    (1) Seed projects will be evaluated collectively on the mechanism
for solicitation of projects and on their technical/scientific merit
review. Evaluation criteria have equal value.
    (2) Small projects will be evaluated individually on the
significance of the

[[Page 66446]]

project, the innovative approach, and the proposed methods for
achieving an investigation sufficient to support a submission of an RO1
level proposal and/or worthy of publication in a peer-reviewed journal
and/or a technical report for a legislative body, governmental agency,
or injury control program.
    (3) Large projects will be evaluated individually according to
existing RO1 level project standards as described in the PHS 398
(Revised 5/01 and updated 6/28/02) guidelines. The application must
have a minimum of one large research project approved in order to be
recommended for further consideration.
    (4) At least 80 percent of the costs (total direct and indirect
costs) of the approved small and large research projects must be in
alignment with the ``CDC Injury Research Agenda,'' http://www.cdc.gov/ncipc
 in order to be recommended for further consideration.
    b. The scientific and technical merit of the overall application,
including the significance and originality (e.g., new topic, new
method, new approach in a new population, or advancing understanding of
the problem) of the proposed research.
    c. The extent to which the evaluation plan will allow for the
measurement of progress toward the achievement of stated objectives.
Does the application specify how the effectiveness of the program will
be measured?
    d. Qualifications, adequacy, and appropriateness of personnel to
accomplish the proposed activities.
    e. The soundness of the proposed budget in terms of adequacy of
resources and their allocation.
    f. In addition to conducting defined research projects, ICRCs are
expected to devote substantial attention to advancing the field through
other activities that are designed to improve research capabilities and
translate research into practice. Examples of activities include:
consultation and technical assistance that are responsive to regional,
State, national, or international priorities; professional training for
researchers and practitioners; program development; and evaluation
endeavors. The degree of effort devoted to these aspects of an ICRC's
program should be clearly stated in the justification and the budget.
The degree of effort may be varied and should reflect the specific
focus and goals of the ICRC.
    g. Details of progress in the most recent funding period should be
provided in the application if the applicant is submitting a re-
competing application. Documented examples of success include:
Development of pilot projects; completion of high quality research
projects; publication of findings in peer reviewed scientific and
technical journals; number of professionals trained; awards received;
ongoing provision of consultation and technical assistance; integration
of disciplines; translation of research into implementation; and impact
on injury control outcomes including legislation, regulation,
treatment, and behavior modification interventions.
    h. Does the application adequately address the requirements of
title 45 CFR part 46 for the protection of human subjects?
    i. Does the applicant meet the CDC Policy requirements regarding
the inclusion of women, ethnic, and racial groups in the proposed
research? This includes:
    (1) The proposed plan for the inclusion of both sexes, racial and
ethnic minority populations for appropriate representation.
    (2) The proposed justification when representation is limited or
absent.
    (3) A statement as to whether the design of the study is adequate
to measure differences when warranted.
    (4) A statement as to whether the plans for recruitment and
outreach for study participants include the process of establishing
partnerships with community or communities and recognition of mutual
benefits.
    j. Does the application adequately address the requirements of the
``PHS Policy on Humane Care and Use of Laboratory Animals by Awardee
Institutions?'
    k. Does the application include measures that are in accordance
with CDC's performance plans?
2. Review by the CDC Advisory Committee for Injury Prevention and
Control (ACIPC)
    Secondary review of ICRC grant applications with a priority score
of 350 or better from the initial peer-review by the IRG will be
conducted by the Science and Program Review Section (SPRS) of the
ACIPC. The SPRS consists of ACIPC members, Federal Ex Officio
participants, and organizational liaisons. The Federal Ex Officio
participants will be responsible for identifying proposals in
overlapping areas of research interest so that unwarranted duplication
in federally funded research can be avoided. The NCIPC Division
Associate Directors for Science (ADS) or their designees will address
the SPRS to assure that research priorities of the announcement are
understood and to provide background regarding current research
activities. The SPRS recommendations will be presented to the entire
ACIPC in the form of a report by the Chairman of the SPRS. The ACIPC
will vote to approve, disapprove, or modify these recommendations for
funding consideration.
    Factors to be considered by the ACIPC include:
    a. The results of the peer-review.
    b. The significance of the proposed activities as they relate to
national program priorities, geographic balance, and the achievement of
national objectives.
    c. The overall balance of the ICRC program in addressing the three
phases of injury control (prevention, acute care, and rehabilitation);
the control of injury among populations who are at increased risk,
including racial/ethnic minority groups, the elderly and children; the
major causes of intentional and unintentional injury; and the major
disciplines of injury control.
    d. Budgetary considerations. The ACIPC will recommend annual
funding levels as detailed in Section II. Award Information,
Approximate Average Award of this announcement.
    These recommendations, based on the results of the peer review by
the IRG, the relevance and balance of the proposed research relative to
the NCIPC programs and priorities, and the assurance of no duplication
of federally-funded research, are presented to the Director, NCIPC, for
funding decisions.
    At the discretion of the Director, NCIPC, additional consideration
may be given to re-competing ICRCs. These centers represent a long-term
investment for NCIPC and an established resource for injury control-
related issues for their States and regions.
3. Continued Funding
    Continuation awards for new awards to this announcement after
federal fiscal year 2004 and within the project period will be made on
the basis of the availability of funds and the following criteria:
    a. The accomplishments of the current budget period show that the
applicant's objectives as prescribed in the yearly work plans are being
met.
    b. The objectives for the new budget period are realistic,
specific, and measurable.
    c. The methods described will clearly lead to achievement of these
objectives.
    d. The evaluation plan allows management to monitor whether the
methods are effective by having clearly defined process, impact, and
outcome objectives, and the applicant demonstrates progress in
implementing the evaluation plan.

[[Page 66447]]

    e. The budget request is clearly explained, adequately justified,
reasonable, and consistent with the intended use of grant funds.

VI. Award Administration Information

    1. Award Notices: If your application is to be funded, you will
receive a Notice of Grant Award (NGA) from the CDC Procurement and
Grants Office. The NGA shall be the only binding, authorizing document
between the recipient and CDC. The NGA will be signed by an authorized
Grants Management Officer, and mailed to the recipient fiscal officer
identified in the application.
    2. Administrative and National Policy Requirements: 45 CFR parts 74
and 92.
    For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
    The following additional requirements apply to this project:

[sbull] AR-1 Human Subjects Requirements
[sbull] AR-2 Requirements for Inclusion of Women and Racial and Ethnic
Minorities in Research
[sbull] AR-3 Animal Subjects Requirements
[sbull] AR-10 Smoke-Free Workplace Requirements
[sbull] AR-11 Healthy People 2010
[sbull] AR-12 Lobbying Restrictions
[sbull] AR-13 Prohibition on Use of CDC Funds for Certain Gun Control
Activities
[sbull] AR-20 Conference Support
[sbull] AR-21 Small, Minority, and Women-Owned Business
[sbull] AR-22 Research Integrity
[sbull] AR-25 Release and Sharing of Data

    Starting with the December 1, 2003 receipt date, all NCIPC funded
investigators seeking more than $250,000 in total costs in a single
year are expected to include a plan describing how the final research
data will be shared/released or explain why data sharing is not
possible. Details on data sharing/release, including the timeliness and
name of the project data steward, should be included in a brief
paragraph immediately following the Research Plan Section of the PHS
398 form. References to data sharing/release may also be appropriate in
other sections of the application (e.g. background and significance,
human subjects requirements, etc.) The content of the data sharing/
release plan will vary, depending on the data being collected and how
the investigator is planning to share the data. The data sharing/
release plan will not count towards the application page limit and will
not factor into the determination scientific merit or priority scores.
Investigators should seek guidance from their institutions, on issues
related to institutional policies, local IRB rules, as well as local,
state and Federal laws and regulations, including the Privacy Rule.
    Further detail on the requirements for addressing data sharing in
applications for NCIPC funding may be obtained by contacting NCIPC
program staff or visiting the NCIPC Internet Web site: at http://www.cdc.gov/ncipc/osp/sharing_policy.htm
.
    Additional information on these requirements can be found on the
CDC web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.
    3. Reporting:
    You must provide CDC with an original, plus two copies of the
following reports:
    1. Interim progress report, (PHS 2590, OMB Number 0925-0001, rev.
5/2001) no less than 90 days before the end of the budget period. The
progress report will serve as your non-competing continuation
application, and must contain the following elements:
    a. Current Budget Period Activities Objectives.
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activity Objectives.
    d. Detailed Line-Item Budget and Justification.
    e. Additional Requested Information.
    2. Financial status report, no more than 90 days after the end of
the budget period.
    3. Final financial and performance reports, no more than 90 days
after the end of the project period.

VII. Agency Contacts

    For general questions about this announcement, contact: Technical
Information Management Section, PA 04057, Procurement and
Grants Office, Centers for Disease Control and Prevention (CDC), 2920
Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-2700.
    For scientific/research program technical assistance, contact:
    Tom Voglesonger, Program Manager, Office of the Associate Director
for Science, National Center for Injury Prevention and Control, Centers
for Disease Control and Prevention (CDC), 4770 Buford Highway, NE,
(K02), Atlanta, GA 30341-3724, Telephone: (770) 488-4823, Email: tdv1@cdc.gov.
    For questions about peer review, contact: Gwendolyn Cattledge, PhD,
Scientific Review Administrator, Office of the Associate Director for
Science, National Center for Injury Prevention and Control, Centers for
Disease Control and Prevention (CDC), 4770 Buford Highway, NE, (K02),
Atlanta, GA 30341-3724, Telephone: (770) 488-1430, E-mail: gxc8@cdc.gov.
    For financial, grants management, or budget assistance, contact:
Van King, Grants Management Specialist, Procurement and Grants Office,
Centers for Disease Control and Prevention (CDC), 2920 Brandywine Road, Atlanta, GA 30341, Telephone: (770) 488-2751, E-mail: vbk5@cdc.gov.

    Dated: November 20, 2003.
Edward Schultz,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 03-29526 Filed 11-25-03; 8:45 am]

BILLING CODE 4163-18-P